(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

GLOBAL CLINICAL INSIGHTS

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

GLOBAL CLINICAL INSIGHTS

ST13

US500000097236524

Class

42

Filing

97236524

Registration

6945082

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

11

Latest update

01/03/2023

Trademark type

Word

Nice classes

42

Filing date

01/25/2022

Registration date

01/03/2023

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

01/03/2023

Last transaction

01/03/2023

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Supplemental Register

First use anywhere

06/28/2020

First use in commerce

06/28/2020

Drawing code

4

Owner type

16

Owner location

Dallas, TX

Examiner

BECKER, JOSEPH

Law office

M80

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

Global Clinical Insights LLC

Representatives

CHET OLSEN SAGE LAW PARTNERS

Technical classification

Nice Classes

Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 42

Medical researchresearch and analysis of data relating to providing oncology care and services

Publications

History of USPTO decisions and trademark events.

11 publications found

NRCS

NOTICE OF REGISTRATION CONFIRMATION EMAILED

01/03/2023

R.SR

REGISTERED-SUPPLEMENTAL REGISTER

01/03/2023

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

11/28/2022

ALIE

ASSIGNED TO LIE

11/21/2022

CNTA

APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER

11/07/2022

XAEC

EXAMINER'S AMENDMENT ENTERED

11/07/2022

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

11/07/2022

GNEA

EXAMINERS AMENDMENT E-MAILED

11/07/2022

CNEA

EXAMINERS AMENDMENT -WRITTEN

11/07/2022

DOCK

ASSIGNED TO EXAMINER

11/04/2022

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

01/31/2022

Continuous trademark protection

Get notified about every new filing that threatens GLOBAL CLINICAL INSIGHTS or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.